Biotech Catalysts This Week: FDA Decisions, Readouts & Earnings (Sep 6–Sep 13, 2026)
No FDA decision dates or earnings reports fall in this week. The nearest regulatory events on the Run-up Radar are NUVL’s NDA decision in 12 days and MIRM’s in 20 days. Among last week’s biotech gainers, SMMT rose 17% on 2.9 times its average volume.
📡 Run-up Radar Highlights
Stocks entering the pre-catalyst window with the strongest setups (full radar is a Premium feature):
- OSTX: Phase 1, Recruiting in 10 days, score 67/100
- NUVL: NDA in 12 days, score 61/100
- MIRM: NDA in 20 days, score 54/100
📈 Last Week’s Biggest Gainers
- SMMT +17.33% (volume 2.9x average)
- HCM +17.19% (volume 9.2x average)
Track your tickers on the BioRadar dashboard →
This digest is for informational purposes only and is not investment advice. Always do your own research.